Filing Details
- Accession Number:
- 0001437749-23-010871
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-24 09:03:00
- Reporting Period:
- 2023-04-21
- Accepted Time:
- 2023-04-24 09:03:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1595248 | Genprex Inc. | GNPX | Pharmaceutical Preparations (2834) | 900772347 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1735543 | Rodney John Varner | 3300 Bee Cave Road #650-227 Austin TX 78746 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-04-21 | 19,000 | $1.06 | 20,800 | No | 4 | P | Indirect | by Alizzita Ltd |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | by Alizzita Ltd |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,159,735 | Direct |
Footnotes
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.0299 to $1.07 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.